| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 5874031 | Journal of Stroke and Cerebrovascular Diseases | 2014 | 8 Pages | 
Abstract
												MMP-9 inhibition represents a potentially effective target for neuroprotection in ICH. However, as a ubiquitous protein, the inhibition of pathologic processes must be balanced against the preservation of neuroprotective angiogenesis. As the opposing roles of MMP-9 may have similar mechanisms, the most important factor may be the timing of MMP-9 inhibition. Further studies are necessary to delineate these mechanisms and their temporal relationship.
											Keywords
												
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Clinical Neurology
												
											Authors
												Jason J. MD, Benjamin A. DO, William J. MD, Giorgios MD, Andrei V. MD, 
											